0001943737-22-000002.txt : 20221028 0001943737-22-000002.hdr.sgml : 20221028 20221028163329 ACCESSION NUMBER: 0001943737-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221028 DATE AS OF CHANGE: 20221028 EFFECTIVENESS DATE: 20221028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pheast Therapeutics, Inc. CENTRAL INDEX KEY: 0001943737 IRS NUMBER: 871616936 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463229 FILM NUMBER: 221342446 BUSINESS ADDRESS: STREET 1: 3160 PORTER DRIVE, STE 210 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 503-270-7172 MAIL ADDRESS: STREET 1: 3160 PORTER DRIVE, STE 210 CITY: PALO ALTO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0708 D LIVE 0001943737 Pheast Therapeutics, Inc. 3160 PORTER DRIVE, STE 210 PALO ALTO CA CALIFORNIA 94304 650-374-2223 DELAWARE None None Corporation true 2020 Amira Barkal 3160 Porter Drive, Ste 210 Palo Alto CA CALIFORNIA 94304 Executive Officer Director Irving Weissman 3160 Porter Drive, Ste 210 Palo Alto CA CALIFORNIA 94304 Director Steven Gillis 3160 Porter Drive, Ste 210 Palo Alto CA CALIFORNIA 94304 Director Jacob Vogelstein 3160 Porter Drive, Ste 210 Palo Alto CA CALIFORNIA 94304 Director Other Technology Decline to Disclose 06b false 2022-01-31 false true false 0 75250000 25224698 50025302 false 7 0 0 0 false Pheast Therapeutics, Inc. /s/ Amira Barkal Amira Barkal CEO 2022-10-28